Presentations

Keynote speakers 

“Aptamers and Aptazymes from an Artificially Expanded Genetic Aplhabet”

Steven Benner, Alachua, FL, USA

“Aptamers and SOMAmers: Biomarker Discovery, Therapeutics, and Insights”

Larry Gold, Boulder, CO, USA

“The foundation of molecular medicine: A chemical biology approach”

Weihong Tan, Hunan, China and Gainesville, FL, USA

Invited speakers 

“Aptamers with Switchable Affinity for Positive Cell Purification”

Maxim Berezovski, Ottawa, Canada

“Aptamers for the selective targeting of glioblastoma cancer stem cells”

Vittorio de Francisis, Naples, Italie

“Time-lapse imaging of in vitro selection using of High-Throughout Sequencing”

Frédéric Ducongé, Fontenay aux Roses, France

“From Plug & Pray to Plug & Play – Aptamer-based transcriptional Riboswitches”

Sven Findeiß, Mario Mörl, Leipzig, Germany

“Selection of DNA aptamers with two modified bases”

Bharat Gawande, Boulder, CO, USA

“Aptamers for the treatment of multiple organ dysfunction”

Paloma Giangrande, Iowa City, IA, USA

“Aptamers for detection of neonatal opioid exposure and detection of deadly cutting  agents in street drugs”

George W. Jackson, TX, USA

“Magneto-dynamic Cancer Therapy by Aptamer-Functionalized Magnetic Nanoparticles in a Low Frequency Alternating Magnetic Field”

Anna S. Kichkailo-Zamay, Krasnoyarsk, Russia

“Development of a subtype-specific diagnostic system for influenza virus H3N2 using a pair of subtype-specific aptamers targeting HA3”

Junyoung Kwon, Pohang, Korea

“New aptamers for metal ions from catalytic DNA”

Juewen Liu, Waterloo, Canada

“Ligand-Guided Selection (LIGS): SELEX Variant to Identify Specific Aptamers Against Cell-surface Markers”

Prabodhika Mallikaratchy, Bronx, NY, USA

“Impairment of membranous ribonucleoprotein signaling reveals a novel strategy for non-Hodgkin lymphoma therapy”

Günter Mayer, Bonn, Germany

“Anti-FGF2 aptamer provides novel therapy for Achondroplasia and age-related macular degeneration”

Yoshikazu Nakamura, Tokyo, Japan

“Insights into the structure and binding properties of one of the shortex G-quadruplex-forming aptamers”

C.K. O’Sullivan, Tarragona, Spain

“RNA Aptamers and their ligand complexes: Shape and Kd determination by native mass spectrometry”

Stefano Piccolo, Bordeaux, France

“A modular cell-internalizing aptamer nanostructure to deliver large functional RNAs”

David Porciani, Columbia, MO, USA

“AptaSWIFT – a novel concept to find aptamers”

Christin Rath, Freiburg, Germany

“Capillary Ellectrophoresis-SELEX: principle and applications”

Corinne Ravelet, Grenoble, France

“Ultrahigh-throughput functional screening of aptamers using droplet-based microfluidics”

Michael Ryckelynck, Strasbourg, France

“Nongenetic Approach for Reprogramming Ligand-Receptor Interaction on Cell Surface Using Bispecific DNA Aptamer”

Shinsuke Sando, Tokyo, Japan

“Targeted delivery of RNA aptamers into the skin as a therapeutic approach for chronic inflammatory skin conditions”

Nicola J. Stonehouse, Leeds, UK

“Development of novel engineered riboswitches”

Beatrix Suess, Darmstadt, Germany

“Precisely Controlling Blood Coagulation with Antithrombotic Aptamers and Antidotes”

Bruce Sullenger, Durham, NC, USA

“Aptamers for Malaria Diagnosis: Structure, Application and Opening the Nano Toolbox”

Julian A. Tanner, Hong Kong SAR, China

“Aptamers, enzymes and nanostructures from synthetic genetic polymers”

Alexander I. Taylor, Cambridge, UK

“Sensing and selecting through a kiss”

Jean-Jacques Toulmé, Bordeaux, France